119: SARON: Stereotactic Ablative Radiotherapy for Oligometastatic Non-small cell lung cancer (NSCLC). A UK randomised phase III trial. (January 2017) - Landau, D.B.; Hughes, L.; Ngai, Y.; Hanna, G.G.; Conibear, J.; Farrelly, L.; Counsell, N.